<DOC>
	<DOC>NCT00840645</DOC>
	<brief_summary>The study is intended to test the safety, tolerability, and efficacy of long-term treatment with YM178 in patients with overactive bladder symptoms.</brief_summary>
	<brief_title>A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Subject has symptoms of overactive bladder for &gt;= 24 wks Subject experiences frequency of micturition at average &gt;= 8 times per 24 hrs confirmed by the 3day patient diary Subject is breastfeeding, pregnant, or intends to become pregnant during the study Subject obviously has stress incontinence Subject has an indwelling catheter or practices intermittent self catheterization Subject has evidence of symptomatic urinary tract infection, interstitial cystitis, bladder stone, etc Subject has an average total daily urine volume &gt; 3000 mL confirmed by patient diary Subject has uncontrollable hypertension (SBP &gt;= 180 mmHg or DBP &gt;= 110 mmHg)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>YM178</keyword>
	<keyword>Urinary Bladder, Overactive</keyword>
	<keyword>Mirabegron</keyword>
</DOC>